These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3900664)

  • 21. Elevated serum neuron-specific enolase in patients with malignant pheochromocytoma.
    Oishi S; Sato T
    Cancer; 1988 Mar; 61(6):1167-70. PubMed ID: 3342373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer.
    Nisman B; Heching N; Biran H; Barak V; Peretz T
    Tumour Biol; 2006; 27(1):8-16. PubMed ID: 16340245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones.
    Nobels FR; Kwekkeboom DJ; Coopmans W; Schoenmakers CH; Lindemans J; De Herder WW; Krenning EP; Bouillon R; Lamberts SW
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2622-8. PubMed ID: 9253344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuron-specific enolase-producing leiomyosarcoma of the mesentery.
    Fukunaga M
    APMIS; 2004 Feb; 112(2):105-8. PubMed ID: 15056226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical study of malignant melanoma.
    Hirano T
    Acta Pathol Jpn; 1986 May; 36(5):733-43. PubMed ID: 3526811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical evaluation of serum NSE (neuron specific enolase) levels in cases of small cell lung cancer].
    Moriya H; Hisa S; Satoh T; Suzuki S; Kimura K; Higuchi Y; Hoshi K
    Rinsho Hoshasen; 1988 Jan; 33(1):31-4. PubMed ID: 2835529
    [No Abstract]   [Full Text] [Related]  

  • 27. Neuron-specific enolase in medullary thyroid carcinoma: immunohistochemical demonstration, but no significance as serum tumor marker.
    Grauer A; Raue F; Rix E; Tschahargane C; Ziegler R
    J Cancer Res Clin Oncol; 1987; 113(6):599-602. PubMed ID: 3316243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological and clinical implication of neuron-specific enolase and creatine kinase BB in small cell lung cancer.
    Ariyoshi Y; Kato K; Ueda R; Takahashi T; Sato T; Akatsuka H; Kuwabara M; Kito K; Suchi T; Nishimura M
    Jpn J Clin Oncol; 1986 Sep; 16(3):213-21. PubMed ID: 3022031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuron-Specific Enolase as an Immunohistochemical Marker Is Better Than Its Reputation.
    Mjønes P; Sagatun L; Nordrum IS; Waldum HL
    J Histochem Cytochem; 2017 Dec; 65(12):687-703. PubMed ID: 28972818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum Neuron-Specific Enolase Levels Predict the Efficacy of First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Patients With Non-Small Cell Lung Cancer Harboring EGFR Mutations.
    Suh KJ; Keam B; Kim M; Park YS; Kim TM; Jeon YK; Kim DW; Chung DH; Kim YW; Heo DS
    Clin Lung Cancer; 2016 Jul; 17(4):245-252.e1. PubMed ID: 26719155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuron specific enolase (NSE) in serum of patients with malignant melanoma.
    Wibe E; Paus E; Aamdal S
    Cancer Lett; 1990 Jun; 52(1):29-31. PubMed ID: 2354416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are levels of pro-gastrin-releasing peptide or neuron-specific enolase at relapse prognostic factors after relapse in patients with small-cell lung cancer?
    Hirose T; Okuda K; Yamaoka T; Ishida K; Kusumoto S; Sugiyama T; Shirai T; Ohnshi T; Ohmori T; Adachi M
    Lung Cancer; 2011 Feb; 71(2):224-8. PubMed ID: 20537424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer].
    Fukuoka M; Takada M; Kamei T; Negoro S; Kusunoki Y; Matsui K; Ryu S; Sakai N; Takifuji N; Masuda N
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):871-80. PubMed ID: 3032108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer.
    van Zandwijk N; Jassem E; Bonfrer JM; Mooi WJ; van Tinteren H
    Semin Oncol; 1992 Feb; 19(1 Suppl 2):37-43. PubMed ID: 1329221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Undifferentiated carcinoma of the liver with neuroendocrine features: a case report.
    Nakasuka H; Okada S; Okusaka T; Ishii H; Ikeda M; Ito R; Kosakamoto H; Yoshimori M; Nakanishi Y; Sakamoto M
    Jpn J Clin Oncol; 1998 Jun; 28(6):401-4. PubMed ID: 9730157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical biochemistry of neuron specific enolase.
    Kaiser E; Kuzmits R; Pregant P; Burghuber O; Worofka W
    Clin Chim Acta; 1989 Jul; 183(1):13-31. PubMed ID: 2548772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects.
    Isgrò MA; Bottoni P; Scatena R
    Adv Exp Med Biol; 2015; 867():125-43. PubMed ID: 26530364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical study of S-100 protein and neuron specific enolase (NSE) in melanocytes and the related tumors.
    Hachisuka H; Sakamoto F; Nomura H; Mori O; Sasai Y
    Acta Histochem; 1986; 80(2):215-23. PubMed ID: 3101377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunocytochemical study of a trabecular carcinoma of the skin (Merkel cell tumor). Case report.
    Carlei F; Lomanto D; Chimenti S; Pranteda G; Castagna G; Lezoche E; Mariani P; D'Alessandro MD; Gendel SE; Speranza V
    Ital J Surg Sci; 1986; 16(1):55-9. PubMed ID: 2424864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical localization of neuron-specific enolase in the human hypophysis and pituitary adenomas.
    Asa SL; Ryan N; Kovacs K; Singer W; Marangos PJ
    Arch Pathol Lab Med; 1984 Jan; 108(1):40-3. PubMed ID: 6362613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.